Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Caspases are a family of cysteine-aspartic proteases that play essential roles in the regulation and execution of programmed cell death processes such as apoptosis, pyroptosis, necroptosis, and PANoptosis. They function by cleaving target proteins at specific aspartic acid residues using a cysteine residue at their active site. There are multiple human caspases classified broadly into initiator caspases (such as caspase‑8 and ‑9) that begin the apoptotic signaling cascade, and effector/executioner caspases (such as caspase‑3, ‑6, ‑7) that dismantle cellular components during apoptosis. Beyond their canonical role in cell death pathways, some caspases also regulate inflammation through processing pro-inflammatory cytokines like IL‑1β; they further participate in non-lethal functions including control over proliferation, differentiation, migration, neural development/axon guidance, gene expression regulation during differentiation processes such as osteogenesis or myogenesis. Dysregulation of the caspase pathway is implicated in various diseases—loss-of-function mutations can contribute to cancer progression by allowing abnormal cells to evade apoptosis; conversely overactivation is linked with neurodegenerative conditions due to excessive neuronal loss. Drugs targeting this pathway include both activators used experimentally for cancer therapy—to induce tumor cell death—and inhibitors being explored for inflammatory/autoimmune conditions where inappropriate activation causes pathology. Monitoring levels of cleaved substrate proteins serves both diagnostic purposes and helps track therapeutic efficacy. Note on correctness: \"Caspase pathway proteins\" is not a single molecular entity but refers collectively to all members involved in the apoptotic/proteolytic cascade mediated by different individual \"caspases.\" For structured data purposes it would be more accurate to specify an individual member such as \"Caspase‑3\" or \"Caspase‑9,\" rather than use this umbrella term.
Induction or inhibition of apoptosis via caspase activation or blockade. Cleavage of specific cellular substrates leading to controlled cell death or modulation of inflammation.
3 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Caspase pathway protein.